PE-22-28
Spadin analog, TREK-1 inhibitor
A synthetic heptapeptide derived from spadin that selectively inhibits TREK-1 potassium channels, promoting neurogenesis and rapid antidepressant effects.
No Clinical Trials Found
Try adjusting your filters to see more results.